GNH USA

Europe — EMA

Paclitaxel Kabi

Paclitaxel, the active ingredient in Paclitaxel Kabi, is a mitotic inhibitor presented as a sterile injectable solution for intravenous use.

Request sourcing

1
Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Kabi, is a mitotic inhibitor presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncology specialists.

GNH USA supplies Paclitaxel Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel Kabi is a chemotherapy agent that interferes with cell division across a range of solid tumours.

- Breast Cancer: It makes the sh sh sh ... -  ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paclitaxel
Route
Intravenous Use
Manufacturer
Fresenius Kabi Pharma Portugal, Lda.
Origin
EU

Related products